Overview

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Status:
Unknown status
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
This research study is studying endostar in combination with chemotherapy as a possible treatment for HER-2 negative advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Endostar protein
Endostatins